Doctor profile · Federal record
Dr. Mary Louise Lenahan, MD
Procedural Dermatology Physician (CMS: Dermatology) · East Amherst, NY
- NPI 1144216953
- MIPS 87.7 / 100 · 2023
- 47 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
6507 Transit RD
East Amherst, NY 140511427
(716) 689-4377
fax (716) 689-4843
Credentials & registration
- NPI registered
- September 2005 — 21 yrs on file
- Profile last updated
- May 20, 2019
- Year of graduation
- 1979 — 47 yrs since
- Specialty taxonomy
- 207NS0135X — NUCC code
- State license (1)
- New York #153446-1
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1144216953. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
800
Distinct HCPCS
8
Medicare allowed
$57,238
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 236 | 190 | $83 | |
17000 |
Destruction of precancer skin growth, 1 growth | 107 | 85 | $48 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 101 | 40 | $6 | |
11102 |
Biopsy of related skin growth, first growth | 97 | 77 | $85 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 96 | 88 | $118 | |
17110 |
Destruction of skin growth, 1-14 growths | 79 | 69 | $104 | |
11103 |
Biopsy of related skin growth, each additional growth | 47 | 29 | $47 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 37 | 35 | $52 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 100. This provider delivers 8.0× the peer median.Open Payments
Industry payments received
All-time total
$1,496
Transactions
74
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 26 | $332.56 | |
| Incyte Corporation | 6 | $167.74 | |
| Amgen Inc. | 6 | $161.96 | |
| Regeneron Healthcare Solutions, Inc. | 3 | $112.77 | |
| UCB, Inc. | 3 | $89.44 | |
| Novartis Pharmaceuticals Corporation | 4 | $78.97 | |
| Galderma Laboratories, L.P. | 5 | $76.82 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $66.17 | |
| Janssen Biotech, Inc. | 3 | $65.25 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $64.90 | |
| Arcutis Biotherapeutics, Inc. | 3 | $50.91 | |
| Lilly USA, LLC | 3 | $50.52 | |
| PFIZER INC. | 2 | $43.80 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43.03 | |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $35.73 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,389
Patients
910
Total drug cost
$244,643
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 237 | 138 | $6,745 |
| Triamcinolone Acetonide | Generic | 226 | 191 | $1,786 |
| Clobetasol Propionate | Generic | 140 | 103 | $6,485 |
| Hydrocortisone | Generic | 115 | 100 | $730 |
| Tacrolimus | Generic | 112 | 50 | $17,168 |
| Doxycycline Hyclate | Generic | 90 | 41 | $1,755 |
| Fluorouracil | Generic | 83 | 80 | $8,384 |
| Prednisone | Generic | 63 | 22 | $298 |
| Terbinafine Hcl | Generic | 56 | 25 | $531 |
| Mupirocin | Generic | 54 | 40 | $498 |
Frequently asked questions
What is Dr. Mary Louise Lenahan's medical specialty?
Dr. Mary Louise Lenahan practices Procedural Dermatology Physician in East Amherst, NY.
Where does Dr. Mary Louise Lenahan practice?
Dr. Mary Louise Lenahan practices at 6507 Transit RD, East Amherst, NY 140511427. Office phone: 7166894377.
What is Dr. Mary Louise Lenahan's NPI?
Dr. Mary Louise Lenahan's National Provider Identifier (NPI) is 1144216953, issued by NPPES.
Does Dr. Mary Louise Lenahan accept Medicare assignment?
Dr. Mary Louise Lenahan does not accept Medicare assignment for all services. Patients may be billed amounts beyond Medicare-allowed charges.
What procedures does Dr. Mary Louise Lenahan commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003). Source: CMS Medicare Physician & Other Practitioners file.